258 related articles for article (PubMed ID: 28018216)
1. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging.
Mooberry LK; Sabnis NA; Panchoo M; Nagarajan B; Lacko AG
Front Pharmacol; 2016; 7():466. PubMed ID: 28018216
[TBL] [Abstract][Full Text] [Related]
2. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.
Shen WJ; Azhar S; Kraemer FB
Annu Rev Physiol; 2018 Feb; 80():95-116. PubMed ID: 29125794
[TBL] [Abstract][Full Text] [Related]
3. Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells.
Martin G; Pilon A; Albert C; Vallé M; Hum DW; Fruchart JC; Najib J; Clavey V; Staels B
Eur J Biochem; 1999 Apr; 261(2):481-91. PubMed ID: 10215860
[TBL] [Abstract][Full Text] [Related]
4. Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy.
Rajora MA; Zheng G
Front Pharmacol; 2016; 7():326. PubMed ID: 27729859
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer.
Gordon JA; Noble JW; Midha A; Derakhshan F; Wang G; Adomat HH; Tomlinson Guns ES; Lin YY; Ren S; Collins CC; Nelson PS; Morrissey C; Wasan KM; Cox ME
Cancer Res; 2019 Jul; 79(13):3320-3331. PubMed ID: 31064850
[TBL] [Abstract][Full Text] [Related]
6. SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer.
Gutierrez-Pajares JL; Ben Hassen C; Chevalier S; Frank PG
Front Pharmacol; 2016; 7():338. PubMed ID: 27774064
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.
Pandey M; Cuddihy G; Gordon JA; Cox ME; Wasan KM
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575583
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism.
Ohgami N; Miyazaki A; Sakai M; Kuniyasu A; Nakayama H; Horiuchi S
J Atheroscler Thromb; 2003; 10(1):1-6. PubMed ID: 12621157
[TBL] [Abstract][Full Text] [Related]
9. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Labeling of Low-Density Lipoprotein Receptor and Scavenger Receptor Class B Type 1 Are Increased in Canine Lymphoma.
Ceres K; Fitzgerald H; Quiznon KS; McDonough S; Behling-Kelly E
Front Vet Sci; 2018; 5():340. PubMed ID: 30687727
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein enhancement of ovarian theca-interstitial cell steroidogenesis: relative contribution of scavenger receptor class B (type I) and adenosine 5'-triphosphate- binding cassette (type A1) transporter in high-density lipoprotein-cholesterol transport and androgen synthesis.
Wu Q; Sucheta S; Azhar S; Menon KM
Endocrinology; 2003 Jun; 144(6):2437-45. PubMed ID: 12746305
[TBL] [Abstract][Full Text] [Related]
12. Expression and microvillar localization of scavenger receptor, class B, type I (a high density lipoprotein receptor) in luteinized and hormone-desensitized rat ovarian models.
Reaven E; Nomoto A; Leers-Sucheta S; Temel R; Williams DL; Azhar S
Endocrinology; 1998 Jun; 139(6):2847-56. PubMed ID: 9607793
[TBL] [Abstract][Full Text] [Related]
13. Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL.
Kinoshita M; Fujita M; Usui S; Maeda Y; Kudo M; Hirota D; Suda T; Taki M; Okazaki M; Teramoto T
Atherosclerosis; 2004 Apr; 173(2):197-202. PubMed ID: 15064092
[TBL] [Abstract][Full Text] [Related]
14. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders.
Rhainds D; Brissette L
Int J Biochem Cell Biol; 2004 Jan; 36(1):39-77. PubMed ID: 14592533
[TBL] [Abstract][Full Text] [Related]
15. Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain.
Connelly MA; de la Llera-Moya M; Monzo P; Yancey PG; Drazul D; Stoudt G; Fournier N; Klein SM; Rothblat GH; Williams DL
Biochemistry; 2001 May; 40(17):5249-59. PubMed ID: 11318648
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma.
Singh A; Nandwana V; Rink JS; Ryoo SR; Chen TH; Allen SD; Scott EA; Gordon LI; Thaxton CS; Dravid VP
ACS Nano; 2019 Sep; 13(9):10301-10311. PubMed ID: 31487458
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer.
Li J; Wang J; Li M; Yin L; Li XA; Zhang TG
Pathol Res Pract; 2016 Jun; 212(6):555-9. PubMed ID: 27067809
[TBL] [Abstract][Full Text] [Related]
18. Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-I compared with LpA-I:A-II lipoprotein particles.
Rinninger F; Brundert M; Budzinski RM; Fruchart JC; Greten H; Castro GR
Atherosclerosis; 2003 Jan; 166(1):31-40. PubMed ID: 12482548
[TBL] [Abstract][Full Text] [Related]
19. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.
Altmann SW; Davis HR; Yao X; Laverty M; Compton DS; Zhu LJ; Crona JH; Caplen MA; Hoos LM; Tetzloff G; Priestley T; Burnett DA; Strader CD; Graziano MP
Biochim Biophys Acta; 2002 Jan; 1580(1):77-93. PubMed ID: 11923102
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells.
Twiddy AL; Cox ME; Wasan KM
Prostate; 2012 Jun; 72(9):955-65. PubMed ID: 22025344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
